Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 502

1.

National platform for Rare Diseases Data Registry of Japan.

Furusawa Y, Yamaguchi I, Yagishita N, Tanzawa K, Matsuda F, Yamano Y; RADDAR‐J Research and Development Group.

Learn Health Syst. 2019 Jan 31;3(3):e10080. doi: 10.1002/lrh2.10080. eCollection 2019 Jul.

PMID:
31317070
2.

In vivo pharmacodynamic study of cefiderocol, a novel parenteral siderophore cephalosporin, in murine thigh and lung infection models.

Nakamura R, Ito-Horiyama T, Takemura M, Toba S, Matsumoto S, Ikehara T, Tsuji M, Sato T, Yamano Y.

Antimicrob Agents Chemother. 2019 Jul 1. pii: AAC.02031-18. doi: 10.1128/AAC.02031-18. [Epub ahead of print]

PMID:
31262762
3.

Isolation of Sesquiterpene-Amino Acid Conjugates, Onopornoids A-D, and a Flavonoid Glucoside from Onopordum alexandrinum.

Sugimoto S, Yamano Y, Desoukey SY, Katakawa K, Wanas AS, Otsuka H, Matsunami K.

J Nat Prod. 2019 Jun 28;82(6):1471-1477. doi: 10.1021/acs.jnatprod.8b00948. Epub 2019 Jun 14.

PMID:
31199638
4.

Four New Flavonoids Isolated from the Aerial Parts of Cadaba rotundifolia Forssk. (Qadab).

Abdulaziz Al-Hamoud G, Saud Orfali R, Sugimoto S, Yamano Y, Alothyqi N, Mohammed Alzahrani A, Matsunami K.

Molecules. 2019 Jun 9;24(11). pii: E2167. doi: 10.3390/molecules24112167.

5.

Proteomic analysis of hippocampal proteins in acrylamide-exposed Wistar rats.

Nagashima D, Zhang L, Kitamura Y, Ichihara S, Watanabe E, Zong C, Yamano Y, Sakurai T, Oikawa S, Ichihara G.

Arch Toxicol. 2019 Jul;93(7):1993-2006. doi: 10.1007/s00204-019-02484-9. Epub 2019 May 23.

PMID:
31123803
6.

8-Pyrenylvinyl Adenine Controls Reversible Duplex Formation between Serinol Nucleic Acid and RNA by [2 + 2] Photocycloaddition.

Murayama K, Yamano Y, Asanuma H.

J Am Chem Soc. 2019 Jun 19;141(24):9485-9489. doi: 10.1021/jacs.9b03267. Epub 2019 May 23.

PMID:
31117655
7.

Reproducibility of broth microdilution MICs for the novel siderophore cephalosporin, cefiderocol, determined using iron-depleted cation-adjusted Mueller-Hinton broth.

Hackel MA, Tsuji M, Yamano Y, Echols R, Karlowsky JA, Sahm DF.

Diagn Microbiol Infect Dis. 2019 Aug;94(4):321-325. doi: 10.1016/j.diagmicrobio.2019.03.003. Epub 2019 Mar 23.

8.

A 10-Year History of Anti-Smoking Campaigns and Enlightenment Activities for Chronic Obstructive Pulmonary Disease for Citizens at the Plaza in Ebina City.

Sato Y, Taniuchi N, Kaburaki S, Aruga N, Kubota K, Seike M, Yamano Y, Gemma A.

J Nippon Med Sch. 2019;86(1):32-37. doi: 10.1272/jnms.JNMS.2019_86-6.

9.

[Changes in the number of female presentations at the annual meeting of the Japan Society for Occupational Health].

Okubo S, Yamauchi T, Yamano Y.

Sangyo Eiseigaku Zasshi. 2019 May 25;61(3):108-114. doi: 10.1539/sangyoeisei.2018-029-S. Epub 2019 Mar 13. Japanese. No abstract available.

10.

Estimation of the effective reproduction number of influenza based on weekly reports in Miyazaki Prefecture.

Yamauchi T, Takeuchi S, Yamano Y, Kuroda Y, Nakadate T.

Sci Rep. 2019 Feb 22;9(1):2539. doi: 10.1038/s41598-019-39057-w.

11.

The Relationship between Walking Speed and Step Length in Older Aged Patients.

Morio Y, Izawa KP, Omori Y, Katata H, Ishiyama D, Koyama S, Yamano Y.

Diseases. 2019 Feb 2;7(1). pii: E17. doi: 10.3390/diseases7010017.

12.

Risk of Human T-Cell Leukemia Virus Type 1 Infection in Kidney Transplantation.

Yamauchi J, Yamano Y, Yuzawa K.

N Engl J Med. 2019 Jan 17;380(3):296-298. doi: 10.1056/NEJMc1809779. No abstract available.

PMID:
30650320
13.

In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015.

Karlowsky JA, Hackel MA, Tsuji M, Yamano Y, Echols R, Sahm DF.

Int J Antimicrob Agents. 2019 Apr;53(4):456-466. doi: 10.1016/j.ijantimicag.2018.11.007. Epub 2018 Nov 22.

14.

Stability and low induction propensity of cefiderocol against chromosomal AmpC β-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae.

Ito A, Nishikawa T, Ota M, Ito-Horiyama T, Ishibashi N, Sato T, Tsuji M, Yamano Y.

J Antimicrob Chemother. 2019 Feb 1;74(2):539. doi: 10.1093/jac/dky482. No abstract available.

15.

Efficacy of Humanized Cefiderocol Exposures over 72 Hours against a Diverse Group of Gram-Negative Isolates in the Neutropenic Murine Thigh Infection Model.

Stainton SM, Monogue ML, Tsuji M, Yamano Y, Echols R, Nicolau DP.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01040-18. doi: 10.1128/AAC.01040-18. Print 2019 Feb.

16.

In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).

Kazmierczak KM, Tsuji M, Wise MG, Hackel M, Yamano Y, Echols R, Sahm DF.

Int J Antimicrob Agents. 2019 Feb;53(2):177-184. doi: 10.1016/j.ijantimicag.2018.10.007. Epub 2018 Oct 26.

17.

Proposed method of histological separation between connective tissue disease-associated interstitial pneumonia and idiopathic interstitial pneumonias.

Ozasa M, Ichikawa H, Sato S, Tanaka T, Johkoh T, Kataoka K, Yamano Y, Kondoh Y, Nakamura H, Kawakami A, Bychkov A, Taniguchi H, Fukuoka J.

PLoS One. 2018 Nov 5;13(11):e0206186. doi: 10.1371/journal.pone.0206186. eCollection 2018.

18.

Carotenoid Profiling of a Red Seaweed Pyropia yezoensis: Insights into Biosynthetic Pathways in the Order Bangiales.

Koizumi J, Takatani N, Kobayashi N, Mikami K, Miyashita K, Yamano Y, Wada A, Maoka T, Hosokawa M.

Mar Drugs. 2018 Nov 1;16(11). pii: E426. doi: 10.3390/md16110426.

19.
21.

Pinopsin evolved as the ancestral dim-light visual opsin in vertebrates.

Sato K, Yamashita T, Kojima K, Sakai K, Matsutani Y, Yanagawa M, Yamano Y, Wada A, Iwabe N, Ohuchi H, Shichida Y.

Commun Biol. 2018 Oct 1;1:156. doi: 10.1038/s42003-018-0164-x. eCollection 2018.

22.

Metabolic abnormalities in adult T-cell leukemia/lymphoma and induction of specific leukemic cell death using photodynamic therapy.

Oka T, Mizuno H, Sakata M, Fujita H, Yoshino T, Yamano Y, Utsumi K, Masujima T, Utsunomiya A.

Sci Rep. 2018 Oct 8;8(1):14979. doi: 10.1038/s41598-018-33175-7.

23.

Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis.

Teramachi R, Kondoh Y, Kataoka K, Taniguchi H, Matsuda T, Kimura T, Yokoyama T, Yamano Y, Furukawa T, Sakamoto K, Hashimoto N, Hasegawa Y.

Respir Med. 2018 Oct;143:147-152. doi: 10.1016/j.rmed.2018.09.011. Epub 2018 Sep 13.

PMID:
30261987
24.

Stability and low induction propensity of cefiderocol against chromosomal AmpC β-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae.

Ito A, Nishikawa T, Ota M, Ito-Horiyama T, Ishibashi N, Sato T, Tsuji M, Yamano Y.

J Antimicrob Chemother. 2018 Nov 1;73(11):3049-3052. doi: 10.1093/jac/dky317. Erratum in: J Antimicrob Chemother. 2019 Feb 1;74(2):539.

25.

Red-Tuning of the Channelrhodopsin Spectrum Using Long Conjugated Retinal Analogues.

Shen YC, Sasaki T, Matsuyama T, Yamashita T, Shichida Y, Okitsu T, Yamano Y, Wada A, Ishizuka T, Yawo H, Imamoto Y.

Biochemistry. 2018 Sep 25;57(38):5544-5556. doi: 10.1021/acs.biochem.8b00583. Epub 2018 Sep 12.

PMID:
30153419
26.

FBLIM1 enhances oral cancer malignancy via modulation of the epidermal growth factor receptor pathway.

Toeda Y, Kasamatsu A, Koike K, Endo-Sakamoto Y, Fushimi K, Kasama H, Yamano Y, Shiiba M, Tanzawa H, Uzawa K.

Mol Carcinog. 2018 Dec;57(12):1690-1697. doi: 10.1002/mc.22889. Epub 2018 Sep 5.

PMID:
30129678
27.

Development of reference material with assigned value for human T-cell leukemia virus type 1 quantitative PCR in Japan.

Kuramitsu M, Okuma K, Nakashima M, Sato T, Sasaki D, Hasegawa H, Umeki K, Kubota R, Sasada K, Sobata R, Matsumoto C, Kaneko N, Tezuka K, Matsuoka S, Utsunomiya A, Koh KR, Ogata M, Ishitsuka K, Taki M, Nosaka K, Uchimaru K, Iwanaga M, Sagara Y, Yamano Y, Okayama A, Miura K, Satake M, Saito S, Watanabe T, Hamaguchi I.

Microbiol Immunol. 2018 Oct;62(10):673-676. doi: 10.1111/1348-0421.12644.

PMID:
30125970
28.

Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity.

Sato T, Yagishita N, Tamaki K, Inoue E, Hasegawa D, Nagasaka M, Suzuki H, Araya N, Coler-Reilly A, Hasegawa Y, Tsuboi Y, Takata A, Yamano Y.

Front Microbiol. 2018 Jul 25;9:1651. doi: 10.3389/fmicb.2018.01651. eCollection 2018.

29.

The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation.

Kawano N, Yoshida S, Kawano S, Kuriyama T, Tahara Y, Toyofuku A, Manabe T, Doi A, Terasaka S, Yamashita K, Ueda Y, Ochiai H, Marutsuka K, Yamano Y, Shimoda K, Kikuchi I.

J Clin Exp Hematop. 2018 Sep 19;58(3):107-121. doi: 10.3960/jslrt.18011. Epub 2018 Aug 8.

30.

Chronic inflammatory demyelinating polyneuropathy in adult T-cell leukemia-lymphoma patients following allogeneic stem cell transplantation.

Hirano M, Jimbo K, Ogawa M, Ochi K, Makiyama J, Kawamata T, Yokoyama K, Tanaka T, Inamoto Y, Yamano Y, Fukuda T, Uchimaru K, Imai Y, Tojo A.

Bone Marrow Transplant. 2018 Nov;53(11):1470-1473. doi: 10.1038/s41409-018-0202-9. Epub 2018 Jul 23. No abstract available.

PMID:
30038356
31.

Multidimensional improvement in connective tissue disease-associated interstitial lung disease: Two courses of pulse dose methylprednisolone followed by low-dose prednisone and tacrolimus.

Yamano Y, Taniguchi H, Kondoh Y, Ando M, Kataoka K, Furukawa T, Johkoh T, Fukuoka J, Sakamoto K, Hasegawa Y.

Respirology. 2018 Nov;23(11):1041-1048. doi: 10.1111/resp.13365. Epub 2018 Jul 16.

32.

Occupational Exposure Limits for ethylidene norbornene, ethyleneimine, benomyl, and 2,3-epoxypropyl methacrylate, and classifications on carcinogenicity.

Committee for Recommendation of Occupational Exposure Limits, Japan Society for Occupational Health, Araki A, Azuma K, Endo G, Endo Y, Fukushima T, Hara K, Hori H, Horie S, Horiguchi H, Ichiba M, Ichihara G, Ikeda M, Ishitake T, Ito A, Ito Y, Iwasawa S, Kakumu T, Kamijima M, Karita K, Katoh T, Kawai T, Kawamoto T, Kumagai S, Kusaka Y, Matsumoto A, Miyagawa M, Miyauchi H, Morimoto Y, Nagano K, Naito H, Nakajima T, Nakano M, Nomiyama T, Okuda H, Okuda M, Omae K, Sakurai H, Sato K, Sobue T, Suwazono Y, Takebayashi T, Takeshita T, Takeuchi A, Takeuchi A, Tanaka M, Tanaka S, Tsukahara T, Tsunoda M, Ueno S, Ueyama J, Umeda Y, Yamamoto K, Yamano Y, Yamauchi T, Yano E.

J Occup Health. 2018 Jul 25;60(4):333-335. doi: 10.1539/joh.2018-0137-OP. Epub 2018 Jul 6. No abstract available.

33.

Correction to: Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan.

Koda M, Iwasaki M, Yamano Y, Lu X, Katoh T.

Environ Health Prev Med. 2018 Jul 4;23(1):30. doi: 10.1186/s12199-018-0718-z.

34.

Cefiderocol (S-649266), A new siderophore cephalosporin exhibiting potent activities against Pseudomonas aeruginosa and other gram-negative pathogens including multi-drug resistant bacteria: Structure activity relationship.

Aoki T, Yoshizawa H, Yamawaki K, Yokoo K, Sato J, Hisakawa S, Hasegawa Y, Kusano H, Sano M, Sugimoto H, Nishitani Y, Sato T, Tsuji M, Nakamura R, Nishikawa T, Yamano Y.

Eur J Med Chem. 2018 Jul 15;155:847-868. doi: 10.1016/j.ejmech.2018.06.014. Epub 2018 Jun 8.

PMID:
29960205
35.

Discovery of Potent and Centrally Active 6-Substituted 5-Fluoro-1,3-dihydro-oxazine β-Secretase (BACE1) Inhibitors via Active Conformation Stabilization.

Nakahara K, Fuchino K, Komano K, Asada N, Tadano G, Hasegawa T, Yamamoto T, Sako Y, Ogawa M, Unemura C, Hosono M, Ito H, Sakaguchi G, Ando S, Ohnishi S, Kido Y, Fukushima T, Dhuyvetter D, Borghys H, Gijsen HJM, Yamano Y, Iso Y, Kusakabe KI.

J Med Chem. 2018 Jul 12;61(13):5525-5546. doi: 10.1021/acs.jmedchem.8b00011. Epub 2018 Jun 14.

PMID:
29775538
36.

Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain.

Fuchino K, Mitsuoka Y, Masui M, Kurose N, Yoshida S, Komano K, Yamamoto T, Ogawa M, Unemura C, Hosono M, Ito H, Sakaguchi G, Ando S, Ohnishi S, Kido Y, Fukushima T, Miyajima H, Hiroyama S, Koyabu K, Dhuyvetter D, Borghys H, Gijsen HJM, Yamano Y, Iso Y, Kusakabe KI.

J Med Chem. 2018 Jun 28;61(12):5122-5137. doi: 10.1021/acs.jmedchem.8b00002. Epub 2018 May 23.

PMID:
29733614
37.

Performance of the St George's Respiratory Questionnaire in patients with connective tissue disease-associated interstitial lung disease.

Suzuki A, Kondoh Y, Swigris JJ, Ando M, Kimura T, Kataoka K, Yamano Y, Furukawa T, Numata M, Sakamoto K, Hasegawa Y.

Respirology. 2018 Mar 25. doi: 10.1111/resp.13293. [Epub ahead of print]

PMID:
29575410
38.

Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy.

Sato T, Coler-Reilly ALG, Yagishita N, Araya N, Inoue E, Furuta R, Watanabe T, Uchimaru K, Matsuoka M, Matsumoto N, Hasegawa Y, Yamano Y.

N Engl J Med. 2018 Feb 8;378(6):529-538. doi: 10.1056/NEJMoa1704827.

39.

BNIP3 expression in bovine follicle and corpus luteum.

Nishimura R, Okuda K, Gunji Y, Khalid AM, Yamano Y, Yamashita Y, Hishinuma M.

J Vet Med Sci. 2018 Mar 2;80(2):368-374. doi: 10.1292/jvms.17-0267. Epub 2017 Dec 19.

40.

Phenolic compounds from the leaves of Breynia officinalis and their tyrosinase and melanogenesis inhibitory activities.

Sasaki A, Yamano Y, Sugimoto S, Otsuka H, Matsunami K, Shinzato T.

J Nat Med. 2018 Mar;72(2):381-389. doi: 10.1007/s11418-017-1148-8. Epub 2017 Dec 20.

PMID:
29264846
41.

Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan.

Koda M, Iwasaki M, Yamano Y, Lu X, Katoh T.

Environ Health Prev Med. 2017 Oct 24;22(1):72. doi: 10.1186/s12199-017-0681-0. Erratum in: Environ Health Prev Med. 2018 Jul 4;23(1):30.

42.

In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016.

Hackel MA, Tsuji M, Yamano Y, Echols R, Karlowsky JA, Sahm DF.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01968-17. doi: 10.1128/AAC.01968-17. Print 2018 Feb.

43.

Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.

Leong ZP, Okida A, Higuchi M, Yamano Y, Hikasa Y.

Vascul Pharmacol. 2018 Jan;100:41-50. doi: 10.1016/j.vph.2017.10.006. Epub 2017 Oct 31.

PMID:
29100963
44.

In Vitro Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria.

Ito A, Sato T, Ota M, Takemura M, Nishikawa T, Toba S, Kohira N, Miyagawa S, Ishibashi N, Matsumoto S, Nakamura R, Tsuji M, Yamano Y.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01454-17. doi: 10.1128/AAC.01454-17. Print 2018 Jan.

45.

Inhibitory effects of ubiquitination of synoviolin by PADI4.

Aratani S, Fujita H, Yagishita N, Yamano Y, Okubo Y, Nishioka K, Nakajima T.

Mol Med Rep. 2017 Dec;16(6):9203-9209. doi: 10.3892/mmr.2017.7764. Epub 2017 Oct 11.

PMID:
29039504
46.

Versatile Amine-Promoted Mild Methanolysis of 3,5-Dinitrobenzoates and Its Application to the Synthesis of Colorado Potato Beetle Pheromone.

Yamano Y, Sasaki H, Wada A.

Chem Pharm Bull (Tokyo). 2017;65(10):940-944. doi: 10.1248/cpb.c17-00462.

47.

Organ involvement pattern suggests subgroups within relapsing polychondritis: comment on the article by Dion et al.

Shimizu J, Yamano Y, Yudoh K, Suzuki N.

Arthritis Rheumatol. 2018 Jan;70(1):148-149. doi: 10.1002/art.40330. Epub 2017 Nov 28. No abstract available.

48.

IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways.

Sawada L, Nagano Y, Hasegawa A, Kanai H, Nogami K, Ito S, Sato T, Yamano Y, Tanaka Y, Masuda T, Kannagi M.

PLoS Pathog. 2017 Sep 14;13(9):e1006597. doi: 10.1371/journal.ppat.1006597. eCollection 2017 Sep.

49.

Efficacy of Humanized Exposures of Cefiderocol (S-649266) against a Diverse Population of Gram-Negative Bacteria in a Murine Thigh Infection Model.

Monogue ML, Tsuji M, Yamano Y, Echols R, Nicolau DP.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01022-17. doi: 10.1128/AAC.01022-17. Print 2017 Nov.

50.

Proviral Features of Human T Cell Leukemia Virus Type 1 in Carriers with Indeterminate Western Blot Analysis Results.

Kuramitsu M, Sekizuka T, Yamochi T, Firouzi S, Sato T, Umeki K, Sasaki D, Hasegawa H, Kubota R, Sobata R, Matsumoto C, Kaneko N, Momose H, Araki K, Saito M, Nosaka K, Utsunomiya A, Koh KR, Ogata M, Uchimaru K, Iwanaga M, Sagara Y, Yamano Y, Okayama A, Miura K, Satake M, Saito S, Itabashi K, Yamaguchi K, Kuroda M, Watanabe T, Okuma K, Hamaguchi I.

J Clin Microbiol. 2017 Sep;55(9):2838-2849. doi: 10.1128/JCM.00659-17. Epub 2017 Jul 12.

Supplemental Content

Loading ...
Support Center